A computational systems biology approach identifies SLUG as a mediator of partial Epithelial-Mesenchymal Transition (EMT) AR Subbalakshmi, S Sahoo, K Biswas, MK Jolly Cells Tissues Organs 211 (6), 689-702, 2022 | 41 | 2022 |
NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype AR Subbalakshmi, D Kundnani, K Biswas, A Ghosh, SM Hanash, ... Frontiers in Oncology 10, 1-12, 2020 | 33 | 2020 |
A non-genetic mechanism involving the integrin β4/Paxillin axis contributes to chemoresistance in lung cancer A Mohanty, A Nam, A Pozhitkov, L Yang, S Srivastava, A Nathan, X Wu, ... Iscience 23 (9), 2020 | 30 | 2020 |
KLF4 induces mesenchymal–epithelial transition (MET) by suppressing multiple EMT-inducing transcription factors AR Subbalakshmi, S Sahoo, I McMullen, AN Saxena, SK Venugopal, ... Cancers 13 (20), 5135, 2021 | 20 | 2021 |
Phenotypic heterogeneity in circulating tumor cells and its prognostic value in metastasis and overall survival K Saxena, AR Subbalakshmi, MK Jolly EBioMedicine 46, 4-5, 2019 | 17 | 2019 |
Lineage plasticity in cancer: the tale of a skin-walker AP Thankamony, AR Subbalakshmi, MK Jolly, R Nair Cancers 13 (14), 3602, 2021 | 15 | 2021 |
Tumor hybrid cells: nature and biological significance MS Tretyakova, AR Subbalakshmi, ME Menyailo, MK Jolly, EV Denisov Frontiers in cell and developmental biology 10, 814714, 2022 | 14 | 2022 |
Phenotypic switching: implications in biology and medicine H Levine, MK Jolly, P Kulkarni, V Nanjundiah Academic Press, 2020 | 13 | 2020 |
The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition AR Subbalakshmi, S Sahoo, P Manjunatha, S Goyal, VA Kasiviswanathan, ... Journal of Biological Engineering 17 (1), 17, 2023 | 12 | 2023 |
Mapping spatiotemporal heterogeneity in tumor profiles by integrating high-throughput imaging and omics analysis PA Patkulkar, AR Subbalakshmi, MK Jolly, S Sinharay ACS omega 8 (7), 6126-6138, 2023 | 8 | 2023 |
Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes AR Subbalakshmi, B Ashraf, MK Jolly Physical Biology 19 (2), 025001, 2022 | 7 | 2022 |
The fundamentals of phenotypic plasticity S Sahoo, AR Subbalakshmi, MK Jolly Phenotypic Switching, 1-21, 2020 | 6 | 2020 |
A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis A Mohanty, A Nam, A Pozhitkov, S Bhattacharya, L Yang, A Nathan, X Wu, ... bioRxiv, 781807, 2019 | 5 | 2019 |
Cancer: More than a geneticist’s Pandora’s box K Saxena, AR Subbalakshmi, P Kulkarni, MK Jolly Journal of Biosciences 47 (2), 21, 2022 | 4 | 2022 |
A Multistep Tumor Growth Model of High-Grade Serous Ovarian Carcinoma Identifies Hypoxia-Associated Signatures MH More, SS Varankar, RR Naik, RD Dhake, P Ray, RM Bankar, AM Mali, ... Cells Tissues Organs, 1-17, 2022 | 1 | 2022 |
Emerging biomarkers and molecular targets for precision medicine in cervical cancer P Garg, M Krishna, AR Subbalakshmi, S Ramisetty, A Mohanty, P Kulkarni, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189106, 2024 | | 2024 |
Dynamical systems biology approach to identify mediators of the Epithelial-Hybrid-Mesenchymal spectrum AR Subbalakshmi | | 2023 |
Unraveling the dangerous duet between cancer cell plasticity and drug resistance N Chatterjee, B Pulipaka, AR Subbalakshmi, MK Jolly, R Nair Computational and Systems Oncology 3 (3), e1051, 2023 | | 2023 |
The Unholy Trinity-Cancer cell plasticity, drug resistance and therapeutic opportunities N Chatterjee, B Pulipaka, AR Subbalakshmi, MK Jolly, R Nair Authorea Preprints, 2023 | | 2023 |
Cancer: More than a geneticist’s Pandora’s box S Kritika, SA Raghu, K Prakash, MK Jolly Journal of Biosciences 47 (2), 2022 | | 2022 |